Psychotropic Medication Use for Youth in Residential Treatment: A Comparison Between Youth with Monopharmacy Versus Polypharmacy

[1]  B. Vitiello,et al.  Clinical messages from the Treatment for Adolescents With Depression Study (TADS). , 2009, The American journal of psychiatry.

[2]  Ronald W. Thompson,et al.  The Changing Mental Health Needs of Youth Admitted to Residential Group Home Care , 2009 .

[3]  Ronald W. Thompson,et al.  Psychotropic medication utilization at a group-home residential facility for children and adolescents. , 2008, Journal of child and adolescent psychopharmacology.

[4]  C. McDougle,et al.  Pharmacotherapy of irritability in pervasive developmental disorders. , 2008, Child and adolescent psychiatric clinics of North America.

[5]  Joseph B. Ryan,et al.  Special Educators' Knowledge Regarding Psychotropic Interventions for Students With Emotional and Behavioral Disorders , 2008 .

[6]  A. Rush,et al.  Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. , 2008, The American journal of psychiatry.

[7]  C. Walrath,et al.  Clinical and Non-Clinical Characteristics Associated with Medication Use Among Children with Serious Emotional Disturbance , 2008 .

[8]  D. Christakis,et al.  Research Ethics in the MySpace Era , 2008, Pediatrics.

[9]  D. Safer,et al.  Psychotropic Medication Patterns Among Youth in Foster Care , 2008, Pediatrics.

[10]  S. Preskorn,et al.  Polypharmacy: When Is It Rational? , 2007, Journal of psychiatric practice.

[11]  B. Vitiello.  Research in child and adolescent psychopharmacology: recent accomplishments and new challenges , 2007, Psychopharmacology.

[12]  A. Dean,et al.  Psychotropic medication utilization in a child and adolescent mental health service. , 2006, Journal of child and adolescent psychopharmacology.

[13]  S. Strakowski,et al.  A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[14]  S. Timimi,et al.  Critical Voices in Child and Adolescent Mental Health , 2006 .

[15]  D. Connor.  Pediatric Psychopharmacology: Fast Facts , 2006 .

[16]  L. Warner,et al.  Youths living away from families in the US mental health system , 2005, The Journal of Behavioral Health Services & Research.

[17]  B. Burns,et al.  Mental Health and Other Service Use by Youth in Therapeutic Foster Care and Group Homes , 2005 .

[18]  T. Mclaughlin,et al.  A naturalistic study of medication reduction in a residential treatment setting. , 2005, Journal of child and adolescent psychopharmacology.

[19]  Ronald T. Brown.  Recent Advances in Pharmacotherapies for the Externalizing Disorders. , 2005 .

[20]  L. Price,et al.  Trends in psychotropic drug use in a child psychiatric hospital from 1991-1998. , 2004, Journal of child and adolescent psychopharmacology.

[21]  H. Wagner,et al.  Use of psychotropic medications by youths in therapeutic foster care and group homes. , 2004, Psychiatric services.

[22]  D. Safer,et al.  Concomitant psychotropic medication for youths. , 2003, The American journal of psychiatry.

[23]  Andrés Martin,et al.  Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. , 2003, Psychiatric services.

[24]  C. Binder,et al.  Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. , 2002, Pediatrics.

[25]  S. Faraone,et al.  Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. , 2002, The international journal of neuropsychopharmacology.

[26]  L. Greenhill.  Stimulant medication treatment of children with attention deficit hyperactivity disorder. , 2002 .

[27]  Marc van Bellinghen,et al.  Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. , 2001 .

[28]  R. Barkley,et al.  A Pilot Study of Methyiphenidate, Clonidine, or the Combination in ADHD Comorbid with Aggressive Oppositional Defiant or Conduct Disorder , 2000, Clinical pediatrics.

[29]  D. Connor,et al.  Combined pharmacotherapy in children and adolescents in a residential treatment center. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[30]  S. Preskorn.  Should rational drug development in psychiatry target more than one mechanism of action in a single molecule , 1995 .

[31]  M. Rapport,et al.  Side effects of methylphenidate and desipramine alone and in combination in children. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

[32]  R. Hawkins,et al.  A scale to measure restrictiveness of living environments for troubled children and youths. , 1992, Hospital & community psychiatry.